Mark A. Attarian
Nessuna posizione attualmente
Profilo
Mark A.
Attarian served as Chief Financial Officer at Track Group, Inc. in 2016.
Prior to that, he was the Chief Financial Officer & Interim EVP at Molecular Insight Pharmaceuticals, Inc. and the Chief Financial Officer & Treasurer at Joslin Diabetes Center, Inc. Attarian received his undergraduate degree from St. Lawrence University.
Precedenti posizioni note di Mark A. Attarian
| Società | Posizione | Fine |
|---|---|---|
| TRACK GROUP, INC. | Direttore Finanziario/CFO | 15/11/2016 |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Direttore Finanziario/CFO | - |
Joslin Diabetes Center, Inc.
 Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA. | Direttore Finanziario/CFO | - |
Formazione di Mark A. Attarian
| St. Lawrence University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TRACK GROUP, INC. | Electronic Technology |
| Aziende private | 2 |
|---|---|
Joslin Diabetes Center, Inc.
Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA. | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
- Borsa valori
- Insiders
- Mark A. Attarian
